Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunodeficiencies and lymphoma].

A Fischer1, C Griscelli

  • 1Groupe de recherches d'immunologie et de rhumatologie pédiatriques, Hôpital des Enfants-Malades, Paris, France.

Bulletin Du Cancer
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD2-induced apoptosis in activated human peripheral T cells: a Fas-independent pathway that requires early protein tyrosine phosphorylation.

Journal of immunology (Baltimore, Md. : 1950)·1996
Same author

Lack of detectable defect in DNA double-strand break repair and DNA-dependent protein kinase activity in radiosensitive human severe combined immunodeficiency fibroblasts.

European journal of immunology·1996
Same author

gamma-c gene transfer into SCID X1 patients' B-cell lines restores normal high-affinity interleukin-2 receptor expression and function.

Blood·1996
Same author

Clinical, hematologic, and biochemical features of a syndrome in Bernese mountain dogs characterized by hepatocerebellar degeneration.

Journal of the American Veterinary Medical Association·1996
Same author

A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Société Française de Greffe de Moelle Osseuse.

British journal of haematology·1996
Same author

Radiommunological measurement of leptin in plasma of obese and diabetic human subjects.

Endocrinology·1996
Same journal

[Off-label use of venetoclax in myeloma].

Bulletin du cancer·2026
Same journal

[Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

Bulletin du cancer·2026
Same journal

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026
Same journal

[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

Bulletin du cancer·2026
Same journal

[Reirradiation: A new therapeutic paradigm in oncology].

Bulletin du cancer·2026
Same journal

[Robotics in oncological surgery].

Bulletin du cancer·2026
See all related articles

Primary immunodeficiencies (ID) significantly increase cancer risk, especially lymphomas. The risk level depends on the ID type, with cellular IDs posing the highest threat.

Area of Science:

  • Immunology
  • Oncology
  • Genetics

Context:

  • Primary immunodeficiencies (ID) are a group of inherited disorders affecting the immune system.
  • These conditions are associated with an increased susceptibility to infections and certain cancers.

Purpose:

  • To review the association between primary immunodeficiencies and cancer risk, with a focus on lymphomas.
  • To explore the varying risks associated with different types of immunodeficiencies.
  • To discuss potential underlying mechanisms for ID-associated lymphomas.

Summary:

  • Primary immunodeficiencies (ID) are linked to a higher incidence of cancers, particularly lymphomas.
  • The risk of developing lymphomas varies significantly based on the type of ID; cellular IDs present a very high risk, tumoral IDs an intermediate risk, and deficiencies in non-specific immunity no increased risk.

Related Experiment Videos

  • Acquired immunodeficiencies also elevate lymphoma risk.
  • The exact mechanisms driving ID-associated lymphomas are still under investigation, with hypotheses including impaired immune surveillance, chronic viral/antigenic stimulation, and DNA repair defects.

    • Impact:

    • Highlights the critical link between immune system defects and cancer development.
    • Underscores the need for tailored cancer surveillance in patients with specific types of immunodeficiencies.
    • Provides a foundation for further research into the pathogenesis of immunodeficiency-associated lymphomas.